Uncommon Therapeutics

Uncommon Therapeutics, founded by Noah, addresses a critical need in treating severe genetic diseases. Inspired by his daughter's diagnosis with Rett Syndrome, a condition affecting 1 in 10,000 girls, Noah leveraged his background as a seasoned tech entrepreneur to develop innovative therapeutic solutions. Uncommon Therapeutics employs a polytherapy strategy that has already demonstrated improvements in the quality of life for patients. The company is focused on designing and developing novel therapeutics, each with the potential to generate billions in value and collectively contribute to a cure for these debilitating diseases. Their approach represents a significant advancement in disease-focused biotechnology.